Search alternatives:
point decrease » point increase (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1581
A Wearable Dual-Modal Patch for Rapid Pre-Hospital Diagnosis of Acute Myocardial Infarction
Published 2025“…The time required for diagnosing ischemia was significantly reduced to 50 min after its onset. The patch is optimally integrated into a stamp-sized band-aid, accompanied by a smartphone app for data visualization and real-time analysis. …”
-
1582
-
1583
-
1584
-
1585
-
1586
-
1587
-
1588
-
1589
Native A1AT effect on efferocytosis receptors expression and ADAM-17 (TACE) activity in CS-exposed AM.
Published 2017“…<b>E.</b> Representative immunoblot of MAR expression in the CS-exposed THP-1 cell lysates and supernatants after treatment with A1AT (Prolastin C, 100 μg/mL, 30 min) or with a pharmacological inhibitor of TACE (TAPI-1, 50 μM, 30 min). …”
-
1590
-
1591
-
1592
-
1593
-
1594
-
1595
-
1596
-
1597
Table_1_Efficacy of Off-Label Therapy for Non-alcoholic Fatty Liver Disease in Improving Non-invasive and Invasive Biomarkers: A Systematic Review and Network Meta-Analysis of Rand...
Published 2022“…Objective<p>To evaluate the effects of vitamin E, pioglitazone, sodium-glucose cotransporter-2 (SGLT2) inhibitors, and glucagon-like peptide-1 (GLP-1) receptor agonists in patients with non-alcoholic fatty liver disease (NAFLD).…”
-
1598
-
1599
-
1600